nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—Fluvastatin—CYP2B6—malignant glioma	0.0146	1	CrCbGaD
Rosuvastatin—Myopathy—Temozolomide—malignant glioma	0.0117	0.0404	CcSEcCtD
Rosuvastatin—Memory impairment—Temozolomide—malignant glioma	0.0105	0.0361	CcSEcCtD
Rosuvastatin—Accidental injury—Carmustine—malignant glioma	0.00962	0.0332	CcSEcCtD
Rosuvastatin—Drug interaction—Carmustine—malignant glioma	0.00917	0.0316	CcSEcCtD
Rosuvastatin—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00869	0.03	CcSEcCtD
Rosuvastatin—Gynaecomastia—Carmustine—malignant glioma	0.00761	0.0263	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Carmustine—malignant glioma	0.0071	0.0245	CcSEcCtD
Rosuvastatin—Gastroenteritis—Temozolomide—malignant glioma	0.00673	0.0232	CcSEcCtD
Rosuvastatin—Injury—Carmustine—malignant glioma	0.00672	0.0232	CcSEcCtD
Rosuvastatin—Hepatic failure—Temozolomide—malignant glioma	0.00664	0.0229	CcSEcCtD
Rosuvastatin—Amnesia—Carmustine—malignant glioma	0.00657	0.0227	CcSEcCtD
Rosuvastatin—Amnesia—Temozolomide—malignant glioma	0.00635	0.0219	CcSEcCtD
Rosuvastatin—SLC7A11—telencephalon—malignant glioma	0.00552	0.0693	CbGeAlD
Rosuvastatin—Muscular weakness—Carmustine—malignant glioma	0.00545	0.0188	CcSEcCtD
Rosuvastatin—Breast disorder—Temozolomide—malignant glioma	0.00539	0.0186	CcSEcCtD
Rosuvastatin—Muscular weakness—Temozolomide—malignant glioma	0.00526	0.0182	CcSEcCtD
Rosuvastatin—Bronchitis—Temozolomide—malignant glioma	0.00496	0.0171	CcSEcCtD
Rosuvastatin—Depression—Carmustine—malignant glioma	0.00475	0.0164	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Carmustine—malignant glioma	0.00467	0.0161	CcSEcCtD
Rosuvastatin—Urinary tract infection—Carmustine—malignant glioma	0.00463	0.016	CcSEcCtD
Rosuvastatin—Depression—Temozolomide—malignant glioma	0.00459	0.0158	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00451	0.0155	CcSEcCtD
Rosuvastatin—Urinary tract infection—Temozolomide—malignant glioma	0.00447	0.0154	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Temozolomide—malignant glioma	0.00435	0.015	CcSEcCtD
Rosuvastatin—Sinusitis—Temozolomide—malignant glioma	0.00432	0.0149	CcSEcCtD
Rosuvastatin—Hepatitis—Temozolomide—malignant glioma	0.00413	0.0142	CcSEcCtD
Rosuvastatin—Pharyngitis—Temozolomide—malignant glioma	0.0041	0.0141	CcSEcCtD
Rosuvastatin—SLC7A11—midbrain—malignant glioma	0.00396	0.0498	CbGeAlD
Rosuvastatin—SLC7A11—spinal cord—malignant glioma	0.00387	0.0486	CbGeAlD
Rosuvastatin—Arrhythmia—Carmustine—malignant glioma	0.00382	0.0132	CcSEcCtD
Rosuvastatin—Mental disorder—Carmustine—malignant glioma	0.00374	0.0129	CcSEcCtD
Rosuvastatin—Mental disorder—Temozolomide—malignant glioma	0.00362	0.0125	CcSEcCtD
Rosuvastatin—HMGCR—telencephalon—malignant glioma	0.00343	0.0431	CbGeAlD
Rosuvastatin—Angioedema—Temozolomide—malignant glioma	0.00328	0.0113	CcSEcCtD
Rosuvastatin—Myalgia—Carmustine—malignant glioma	0.00317	0.0109	CcSEcCtD
Rosuvastatin—Cough—Temozolomide—malignant glioma	0.00314	0.0108	CcSEcCtD
Rosuvastatin—SLC7A11—central nervous system—malignant glioma	0.00314	0.0394	CbGeAlD
Rosuvastatin—SLC7A11—cerebellum—malignant glioma	0.00306	0.0385	CbGeAlD
Rosuvastatin—Confusional state—Carmustine—malignant glioma	0.00306	0.0106	CcSEcCtD
Rosuvastatin—Arthralgia—Temozolomide—malignant glioma	0.00306	0.0106	CcSEcCtD
Rosuvastatin—Myalgia—Temozolomide—malignant glioma	0.00306	0.0106	CcSEcCtD
Rosuvastatin—Infection—Carmustine—malignant glioma	0.00302	0.0104	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Carmustine—malignant glioma	0.00297	0.0103	CcSEcCtD
Rosuvastatin—Confusional state—Temozolomide—malignant glioma	0.00296	0.0102	CcSEcCtD
Rosuvastatin—Infection—Temozolomide—malignant glioma	0.00291	0.0101	CcSEcCtD
Rosuvastatin—SLCO2B1—telencephalon—malignant glioma	0.00291	0.0365	CbGeAlD
Rosuvastatin—Nervous system disorder—Temozolomide—malignant glioma	0.00288	0.00992	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Temozolomide—malignant glioma	0.00287	0.00991	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00277	0.00954	CcSEcCtD
Rosuvastatin—Insomnia—Carmustine—malignant glioma	0.00275	0.00947	CcSEcCtD
Rosuvastatin—Paraesthesia—Carmustine—malignant glioma	0.00273	0.0094	CcSEcCtD
Rosuvastatin—HMGCR—medulla oblongata—malignant glioma	0.00269	0.0338	CbGeAlD
Rosuvastatin—SLCO1A2—telencephalon—malignant glioma	0.00267	0.0336	CbGeAlD
Rosuvastatin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00267	0.00922	CcSEcCtD
Rosuvastatin—Insomnia—Temozolomide—malignant glioma	0.00265	0.00915	CcSEcCtD
Rosuvastatin—Paraesthesia—Temozolomide—malignant glioma	0.00263	0.00908	CcSEcCtD
Rosuvastatin—Pain—Carmustine—malignant glioma	0.0026	0.00895	CcSEcCtD
Rosuvastatin—Constipation—Carmustine—malignant glioma	0.0026	0.00895	CcSEcCtD
Rosuvastatin—Dyspepsia—Temozolomide—malignant glioma	0.00258	0.00891	CcSEcCtD
Rosuvastatin—Pain—Temozolomide—malignant glioma	0.00251	0.00865	CcSEcCtD
Rosuvastatin—Constipation—Temozolomide—malignant glioma	0.00251	0.00865	CcSEcCtD
Rosuvastatin—Feeling abnormal—Carmustine—malignant glioma	0.0025	0.00863	CcSEcCtD
Rosuvastatin—SLC7A11—brain—malignant glioma	0.00249	0.0313	CbGeAlD
Rosuvastatin—Gastrointestinal pain—Carmustine—malignant glioma	0.00248	0.00856	CcSEcCtD
Rosuvastatin—HMGCR—midbrain—malignant glioma	0.00246	0.0309	CbGeAlD
Rosuvastatin—Feeling abnormal—Temozolomide—malignant glioma	0.00242	0.00834	CcSEcCtD
Rosuvastatin—HMGCR—spinal cord—malignant glioma	0.0024	0.0302	CbGeAlD
Rosuvastatin—Abdominal pain—Carmustine—malignant glioma	0.0024	0.00828	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Temozolomide—malignant glioma	0.0024	0.00827	CcSEcCtD
Rosuvastatin—Urticaria—Temozolomide—malignant glioma	0.00233	0.00804	CcSEcCtD
Rosuvastatin—Abdominal pain—Temozolomide—malignant glioma	0.00232	0.008	CcSEcCtD
Rosuvastatin—SLCO2B1—medulla oblongata—malignant glioma	0.00228	0.0287	CbGeAlD
Rosuvastatin—Hypersensitivity—Carmustine—malignant glioma	0.00224	0.00771	CcSEcCtD
Rosuvastatin—ABCC1—telencephalon—malignant glioma	0.00219	0.0276	CbGeAlD
Rosuvastatin—Asthenia—Carmustine—malignant glioma	0.00218	0.00751	CcSEcCtD
Rosuvastatin—Hypersensitivity—Temozolomide—malignant glioma	0.00216	0.00745	CcSEcCtD
Rosuvastatin—Asthenia—Temozolomide—malignant glioma	0.0021	0.00726	CcSEcCtD
Rosuvastatin—SLCO1A2—medulla oblongata—malignant glioma	0.0021	0.0264	CbGeAlD
Rosuvastatin—Diarrhoea—Carmustine—malignant glioma	0.00208	0.00716	CcSEcCtD
Rosuvastatin—Pruritus—Temozolomide—malignant glioma	0.00208	0.00716	CcSEcCtD
Rosuvastatin—SLCO2B1—spinal cord—malignant glioma	0.00204	0.0256	CbGeAlD
Rosuvastatin—Dizziness—Carmustine—malignant glioma	0.00201	0.00692	CcSEcCtD
Rosuvastatin—Diarrhoea—Temozolomide—malignant glioma	0.00201	0.00692	CcSEcCtD
Rosuvastatin—HMGCR—central nervous system—malignant glioma	0.00195	0.0245	CbGeAlD
Rosuvastatin—Dizziness—Temozolomide—malignant glioma	0.00194	0.00669	CcSEcCtD
Rosuvastatin—SLCO1A2—midbrain—malignant glioma	0.00192	0.0241	CbGeAlD
Rosuvastatin—Rash—Carmustine—malignant glioma	0.00191	0.0066	CcSEcCtD
Rosuvastatin—Dermatitis—Carmustine—malignant glioma	0.00191	0.0066	CcSEcCtD
Rosuvastatin—HMGCR—cerebellum—malignant glioma	0.00191	0.0239	CbGeAlD
Rosuvastatin—Headache—Carmustine—malignant glioma	0.0019	0.00656	CcSEcCtD
Rosuvastatin—SLCO1A2—spinal cord—malignant glioma	0.00187	0.0235	CbGeAlD
Rosuvastatin—Rash—Temozolomide—malignant glioma	0.00185	0.00638	CcSEcCtD
Rosuvastatin—Dermatitis—Temozolomide—malignant glioma	0.00185	0.00637	CcSEcCtD
Rosuvastatin—Headache—Temozolomide—malignant glioma	0.00184	0.00634	CcSEcCtD
Rosuvastatin—ABCG2—telencephalon—malignant glioma	0.00182	0.0228	CbGeAlD
Rosuvastatin—Nausea—Carmustine—malignant glioma	0.0018	0.00622	CcSEcCtD
Rosuvastatin—Nausea—Temozolomide—malignant glioma	0.00174	0.00601	CcSEcCtD
Rosuvastatin—SLCO2B1—central nervous system—malignant glioma	0.00165	0.0207	CbGeAlD
Rosuvastatin—SLCO2B1—cerebellum—malignant glioma	0.00161	0.0203	CbGeAlD
Rosuvastatin—HMGCR—brain—malignant glioma	0.00155	0.0194	CbGeAlD
Rosuvastatin—SLCO1A2—central nervous system—malignant glioma	0.00152	0.0191	CbGeAlD
Rosuvastatin—SLCO1A2—cerebellum—malignant glioma	0.00149	0.0187	CbGeAlD
Rosuvastatin—ABCC4—central nervous system—malignant glioma	0.00146	0.0184	CbGeAlD
Rosuvastatin—ABCG2—medulla oblongata—malignant glioma	0.00143	0.0179	CbGeAlD
Rosuvastatin—SLCO2B1—brain—malignant glioma	0.00131	0.0165	CbGeAlD
Rosuvastatin—ABCG2—midbrain—malignant glioma	0.0013	0.0164	CbGeAlD
Rosuvastatin—ABCG2—spinal cord—malignant glioma	0.00127	0.016	CbGeAlD
Rosuvastatin—ABCC1—cerebellum—malignant glioma	0.00122	0.0153	CbGeAlD
Rosuvastatin—SLCO1A2—brain—malignant glioma	0.00121	0.0152	CbGeAlD
Rosuvastatin—ALB—brain—malignant glioma	0.0012	0.0151	CbGeAlD
Rosuvastatin—ABCC4—brain—malignant glioma	0.00116	0.0146	CbGeAlD
Rosuvastatin—ABCG2—cerebellum—malignant glioma	0.00101	0.0127	CbGeAlD
Rosuvastatin—ABCC1—brain—malignant glioma	0.00099	0.0124	CbGeAlD
Rosuvastatin—ABCG2—brain—malignant glioma	0.00082	0.0103	CbGeAlD
Rosuvastatin—CYP3A4—central nervous system—malignant glioma	0.000719	0.00903	CbGeAlD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000107	0.000174	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000107	0.000173	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000106	0.000172	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000106	0.000172	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—CAV1—malignant glioma	0.000106	0.000172	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYP2B6—malignant glioma	0.000106	0.000172	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—GSTP1—malignant glioma	0.000106	0.000171	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—CAV1—malignant glioma	0.000105	0.000171	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—COX8A—malignant glioma	0.000105	0.000171	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—SPHK1—malignant glioma	0.000104	0.000169	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CAT—malignant glioma	0.000103	0.000167	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—IDH2—malignant glioma	0.000103	0.000167	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CYP2C18—malignant glioma	0.000102	0.000166	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—TERT—malignant glioma	0.000102	0.000166	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HLA-A—malignant glioma	0.000102	0.000166	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CG—malignant glioma	0.000102	0.000165	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000102	0.000165	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PIK3CB—malignant glioma	0.000102	0.000165	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—F2—malignant glioma	0.000101	0.000164	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—FN1—malignant glioma	0.000101	0.000164	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PTGS2—malignant glioma	0.000101	0.000163	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000101	0.000163	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—GSTP1—malignant glioma	0.0001	0.000163	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PDGFB—malignant glioma	9.96e-05	0.000162	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—PIK3CA—malignant glioma	9.96e-05	0.000162	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—FGFR1—malignant glioma	9.91e-05	0.000161	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PPARG—malignant glioma	9.83e-05	0.00016	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HIF1A—malignant glioma	9.76e-05	0.000158	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CAT—malignant glioma	9.76e-05	0.000158	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—NCOR1—malignant glioma	9.7e-05	0.000157	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—IDH1—malignant glioma	9.68e-05	0.000157	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.68e-05	0.000157	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP2B6—malignant glioma	9.65e-05	0.000157	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CG—malignant glioma	9.64e-05	0.000157	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.64e-05	0.000157	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—TP53—malignant glioma	9.63e-05	0.000156	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GSTT1—malignant glioma	9.6e-05	0.000156	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CG—malignant glioma	9.59e-05	0.000156	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—EGF—malignant glioma	9.53e-05	0.000155	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PTPN11—malignant glioma	9.48e-05	0.000154	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CAV1—malignant glioma	9.44e-05	0.000153	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SPHK1—malignant glioma	9.37e-05	0.000152	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—GSTP1—malignant glioma	9.29e-05	0.000151	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PPARG—malignant glioma	9.25e-05	0.00015	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—NCOR1—malignant glioma	9.22e-05	0.00015	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYP2C18—malignant glioma	9.18e-05	0.000149	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CAT—malignant glioma	9.04e-05	0.000147	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTGS1—malignant glioma	9e-05	0.000146	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CD—malignant glioma	8.96e-05	0.000145	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ASMT—malignant glioma	8.93e-05	0.000145	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—BAD—malignant glioma	8.88e-05	0.000144	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—IDH1—malignant glioma	8.83e-05	0.000143	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—AKT2—malignant glioma	8.82e-05	0.000143	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—NOTCH1—malignant glioma	8.79e-05	0.000143	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CAV1—malignant glioma	8.79e-05	0.000143	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.78e-05	0.000143	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PTEN—malignant glioma	8.78e-05	0.000143	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	8.74e-05	0.000142	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.65e-05	0.000141	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CD80—malignant glioma	8.62e-05	0.00014	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—APC—malignant glioma	8.6e-05	0.00014	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SPHK1—malignant glioma	8.54e-05	0.000139	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—NCOR1—malignant glioma	8.53e-05	0.000139	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—EGF—malignant glioma	8.5e-05	0.000138	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CD—malignant glioma	8.48e-05	0.000138	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.47e-05	0.000138	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTPN11—malignant glioma	8.45e-05	0.000137	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CD—malignant glioma	8.43e-05	0.000137	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—BCAN—malignant glioma	8.4e-05	0.000136	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.39e-05	0.000136	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP2C18—malignant glioma	8.37e-05	0.000136	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—BCHE—malignant glioma	8.36e-05	0.000136	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GSTT1—malignant glioma	8.27e-05	0.000134	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—SLC5A5—malignant glioma	8.26e-05	0.000134	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—AKT1—malignant glioma	8.13e-05	0.000132	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—BRAF—malignant glioma	8.08e-05	0.000131	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CG—malignant glioma	8e-05	0.00013	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CAV1—malignant glioma	7.91e-05	0.000128	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.89e-05	0.000128	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.88e-05	0.000128	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—AKT2—malignant glioma	7.87e-05	0.000128	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CB—malignant glioma	7.81e-05	0.000127	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTGS1—malignant glioma	7.75e-05	0.000126	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PTGS2—malignant glioma	7.73e-05	0.000126	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PPARG—malignant glioma	7.72e-05	0.000125	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.72e-05	0.000125	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.61e-05	0.000124	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—RAF1—malignant glioma	7.57e-05	0.000123	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PIK3CD—malignant glioma	7.56e-05	0.000123	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.55e-05	0.000123	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CAV1—malignant glioma	7.51e-05	0.000122	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GSTT1—malignant glioma	7.42e-05	0.000121	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CB—malignant glioma	7.39e-05	0.00012	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CB—malignant glioma	7.35e-05	0.000119	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PTGS2—malignant glioma	7.28e-05	0.000118	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—FGF2—malignant glioma	7.24e-05	0.000118	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—BCHE—malignant glioma	7.2e-05	0.000117	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CG—malignant glioma	7.2e-05	0.000117	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.19e-05	0.000117	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.18e-05	0.000117	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	7.14e-05	0.000116	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—SLC5A5—malignant glioma	7.11e-05	0.000116	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CD—malignant glioma	7.04e-05	0.000114	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CAV1—malignant glioma	6.96e-05	0.000113	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTGS1—malignant glioma	6.95e-05	0.000113	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PPARG—malignant glioma	6.95e-05	0.000113	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.94e-05	0.000113	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.93e-05	0.000113	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CG—malignant glioma	6.84e-05	0.000111	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—IL2—malignant glioma	6.79e-05	0.00011	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MDM2—malignant glioma	6.77e-05	0.00011	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—IDH2—malignant glioma	6.77e-05	0.00011	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GSTT1—malignant glioma	6.77e-05	0.00011	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—RAF1—malignant glioma	6.75e-05	0.00011	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PTEN—malignant glioma	6.74e-05	0.00011	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.73e-05	0.000109	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—ERBB2—malignant glioma	6.68e-05	0.000108	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.67e-05	0.000108	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GSTP1—malignant glioma	6.65e-05	0.000108	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PPARG—malignant glioma	6.61e-05	0.000107	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PIK3CB—malignant glioma	6.59e-05	0.000107	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	6.55e-05	0.000106	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTGS2—malignant glioma	6.53e-05	0.000106	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CAT—malignant glioma	6.48e-05	0.000105	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—BCHE—malignant glioma	6.47e-05	0.000105	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.39e-05	0.000104	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.36e-05	0.000103	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PTEN—malignant glioma	6.35e-05	0.000103	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTGS1—malignant glioma	6.34e-05	0.000103	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CG—malignant glioma	6.34e-05	0.000103	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CD—malignant glioma	6.33e-05	0.000103	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.32e-05	0.000103	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PIK3CA—malignant glioma	6.19e-05	0.000101	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CB—malignant glioma	6.13e-05	9.96e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PPARG—malignant glioma	6.12e-05	9.93e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—NCOR1—malignant glioma	6.12e-05	9.93e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTGS2—malignant glioma	6.08e-05	9.87e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.04e-05	9.81e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CD—malignant glioma	6.02e-05	9.77e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.98e-05	9.72e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—BCHE—malignant glioma	5.9e-05	9.57e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SLC5A5—malignant glioma	5.82e-05	9.46e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—IDH1—malignant glioma	5.82e-05	9.45e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.81e-05	9.44e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—VEGFA—malignant glioma	5.77e-05	9.37e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GSTP1—malignant glioma	5.73e-05	9.31e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTEN—malignant glioma	5.69e-05	9.25e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SPHK1—malignant glioma	5.63e-05	9.15e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CAT—malignant glioma	5.58e-05	9.05e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CD—malignant glioma	5.57e-05	9.05e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.52e-05	8.96e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CB—malignant glioma	5.52e-05	8.96e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.51e-05	8.94e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTGS2—malignant glioma	5.47e-05	8.88e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.46e-05	8.86e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTEN—malignant glioma	5.3e-05	8.6e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NCOR1—malignant glioma	5.27e-05	8.55e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CB—malignant glioma	5.24e-05	8.52e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.22e-05	8.47e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTGS2—malignant glioma	5.2e-05	8.44e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GSTP1—malignant glioma	5.14e-05	8.35e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—STAT3—malignant glioma	5.09e-05	8.27e-05	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—AKT1—malignant glioma	5.06e-05	8.22e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CAT—malignant glioma	5.01e-05	8.13e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CAV1—malignant glioma	4.98e-05	8.09e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—KRAS—malignant glioma	4.9e-05	7.96e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CB—malignant glioma	4.86e-05	7.88e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTGS2—malignant glioma	4.81e-05	7.81e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTEN—malignant glioma	4.77e-05	7.74e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.76e-05	7.73e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CA—malignant glioma	4.76e-05	7.73e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MYC—malignant glioma	4.73e-05	7.68e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NCOR1—malignant glioma	4.73e-05	7.68e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GSTP1—malignant glioma	4.69e-05	7.62e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—EGFR—malignant glioma	4.63e-05	7.52e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CAT—malignant glioma	4.56e-05	7.41e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CG—malignant glioma	4.54e-05	7.37e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTEN—malignant glioma	4.53e-05	7.36e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CA—malignant glioma	4.51e-05	7.32e-05	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CA—malignant glioma	4.48e-05	7.27e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTT1—malignant glioma	4.46e-05	7.25e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PPARG—malignant glioma	4.38e-05	7.12e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—KRAS—malignant glioma	4.37e-05	7.1e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TP53—malignant glioma	4.36e-05	7.08e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NCOR1—malignant glioma	4.31e-05	7e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CAV1—malignant glioma	4.29e-05	6.97e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTEN—malignant glioma	4.2e-05	6.81e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTGS1—malignant glioma	4.18e-05	6.79e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.1e-05	6.66e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PIK3CA—malignant glioma	4.02e-05	6.52e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.99e-05	6.48e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CG—malignant glioma	3.91e-05	6.35e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—BCHE—malignant glioma	3.89e-05	6.31e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—AKT1—malignant glioma	3.89e-05	6.31e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CAV1—malignant glioma	3.85e-05	6.26e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.84e-05	6.24e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PPARG—malignant glioma	3.77e-05	6.13e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CA—malignant glioma	3.74e-05	6.07e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.68e-05	5.98e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—AKT1—malignant glioma	3.68e-05	5.98e-05	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—AKT1—malignant glioma	3.66e-05	5.94e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CAV1—malignant glioma	3.51e-05	5.71e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.51e-05	5.7e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.48e-05	5.65e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTGS2—malignant glioma	3.45e-05	5.6e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CD—malignant glioma	3.44e-05	5.58e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PPARG—malignant glioma	3.39e-05	5.5e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CA—malignant glioma	3.36e-05	5.46e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.36e-05	5.45e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—AKT1—malignant glioma	3.28e-05	5.33e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.2e-05	5.2e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CA—malignant glioma	3.2e-05	5.19e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTP1—malignant glioma	3.09e-05	5.02e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PPARG—malignant glioma	3.09e-05	5.02e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.09e-05	5.01e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—AKT1—malignant glioma	3.05e-05	4.96e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CAT—malignant glioma	3.01e-05	4.89e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTEN—malignant glioma	3.01e-05	4.88e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CB—malignant glioma	3e-05	4.87e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTGS2—malignant glioma	2.97e-05	4.82e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CA—malignant glioma	2.96e-05	4.81e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NCOR1—malignant glioma	2.84e-05	4.62e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.81e-05	4.57e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—AKT1—malignant glioma	2.75e-05	4.46e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.69e-05	4.37e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTGS2—malignant glioma	2.67e-05	4.33e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—AKT1—malignant glioma	2.61e-05	4.24e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTEN—malignant glioma	2.59e-05	4.2e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.45e-05	3.98e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTGS2—malignant glioma	2.43e-05	3.95e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—AKT1—malignant glioma	2.42e-05	3.93e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTEN—malignant glioma	2.32e-05	3.77e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CAV1—malignant glioma	2.32e-05	3.76e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.12e-05	3.44e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTEN—malignant glioma	2.12e-05	3.44e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.11e-05	3.43e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PPARG—malignant glioma	2.04e-05	3.31e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.86e-05	3.01e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CA—malignant glioma	1.83e-05	2.97e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—AKT1—malignant glioma	1.73e-05	2.81e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.64e-05	2.66e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.62e-05	2.63e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTGS2—malignant glioma	1.6e-05	2.6e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.5e-05	2.43e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—AKT1—malignant glioma	1.49e-05	2.42e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTEN—malignant glioma	1.4e-05	2.27e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—AKT1—malignant glioma	1.34e-05	2.18e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—AKT1—malignant glioma	1.22e-05	1.98e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.86e-06	1.6e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—AKT1—malignant glioma	8.06e-06	1.31e-05	CbGpPWpGaD
